Cargando…

Prevention of EAE in non-human primates by a type IV phosphodiesterase inhibitor that suppresses tumor necrosis factor

Detalles Bibliográficos
Autores principales:	Genain, C.P., Nguyen, M.H., Faulds, D., Uccelli, A., Davis, R.L., Hedgpeth, J., Hauser, S.L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 1994
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119632/ http://dx.doi.org/10.1016/0165-5728(94)90326-3

Ejemplares similares

Rethinking EAE pathogenesis
por: Van Epps, Heather L.
Publicado: (2005)

PARing down EAE
por: Van Epps, Heather L.
Publicado: (2006)

Thomas Rivers and the EAE model
por: Van Epps, Heather L.
Publicado: (2005)

The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis
por: ‘T Hart, Bert A., et al.
Publicado: (2013)

NLRP3 Inflammasome and MS/EAE
por: Inoue, Makoto, et al.
Publicado: (2013)

Active Suppression Induced by Repetitive Self-Epitopes Protects against EAE Development
por: Puentes, Fabiola, et al.
Publicado: (2013)

Role of Microglia and Macrophages in Eae
por: Raivich, Gennadij, et al.
Publicado: (2005)

Phosphodiesterase IV inhibitors as therapy for eosinophil-induced lung injury in asthma.
por: Torphy, T J, et al.
Publicado: (1994)

Bone Marrow Transfer in Relapsing-Remitting EAE Ameliorates Disease at First Remission, with No Synergistic Effect upon Co-Transplantation with Mesenchymal Stem Cells
por: Ferrara, Giovanni, et al.
Publicado: (2021)

Inhibition of calcium-calmodulin-dependent phosphodiesterase (PDE1) suppresses inflammatory responses
por: O'Brien, Jennifer J., et al.
Publicado: (2019)

Recoverin Regulates Light-dependent Phosphodiesterase Activity in Retinal Rods
por: Makino, Clint L., et al.
Publicado: (2004)

Rolipram: Eotaxin and phosphodiesterase IV inhibitor versus bronchial hyper-reactivity response
por: Khan, Hamza Hassan, et al.
Publicado: (2015)

The EAES intellectual property awareness survey
por: Nakajima, Kiyokazu, et al.
Publicado: (2021)

Oral vancomycin treatment suppresses gut trypsin activity and preserves intestinal barrier function during EAE
por: Bianchimano, Paola, et al.
Publicado: (2023)

Overexpression of GSN could decrease inflammation and apoptosis in EAE and may enhance vitamin D therapy on EAE/MS
por: Gao, Jifang, et al.
Publicado: (2017)

Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE
por: Bruzzone, Santina, et al.
Publicado: (2009)

Ongoing Oxidative Stress Causes Subclinical Neuronal Dysfunction in the Recovery Phase of EAE
por: Radbruch, Helena, et al.
Publicado: (2016)

Extended Freeze-Dried BCG Instructed pDCs Induce Suppressive Tregs and Dampen EAE
por: Lippens, Carla, et al.
Publicado: (2018)

TnP Peptide Suppresses Experimental Autoimmune Encephalomyelitis (EAE) in a Preclinical Mouse Model
por: Lima, Carla, et al.
Publicado: (2022)

ALEFACEPT PROMOTES COSTIMULATION BLOCKADE BASED ALLOGRAFT SURVIVAL IN PRIMATES
por: Weaver, T.A., et al.
Publicado: (2009)

Phosphodiesterase 4 inhibition but not beta-adrenergic stimulation suppresses tumor necrosis factor-alpha release in peripheral blood mononuclear cells in septic shock
por: Link, Andreas, et al.
Publicado: (2008)

Regionally diverse astrocyte subtypes and their heterogeneous response to EAE
por: Borggrewe, Malte, et al.
Publicado: (2020)

Increased activity of IRE1 improves the clinical presentation of EAE
por: Bracchi-Ricard, Valerie, et al.
Publicado: (2023)

Chemokine receptor expression by inflammatory T cells in EAE
por: Mony, Jyothi Thyagabhavan, et al.
Publicado: (2014)

Notch Signaling and T-Helper Cells in EAE/MS
por: Bassil, Ribal, et al.
Publicado: (2013)

Neutrophil-related factors as biomarkers in EAE and MS
por: Rumble, Julie M., et al.
Publicado: (2015)

Operating hurts: a study of EAES surgeons
por: Wells, Antonia C., et al.
Publicado: (2018)

Mechanisms of sex hormones in autoimmunity: focus on EAE
por: Lasrado, Ninaad, et al.
Publicado: (2020)

Nox2-dependent Neuroinflammation in An EAE Model of Multiple Sclerosis
por: Ravelli, Katherine G., et al.
Publicado: (2019)

EXPERIMENTAL LIVER NECROSIS; IV. NUCLEIN METABOLISMS
por: Jackson, Holmes C., et al.
Publicado: (1907)

CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
por: Fransson, Moa, et al.
Publicado: (2012)

Comprehensive Analysis of the Immune and Stromal Compartments of the CNS in EAE Mice Reveal Pathways by Which Chloroquine Suppresses Neuroinflammation
por: Thome, Rodolfo, et al.
Publicado: (2020)

CD47 antibody blockade suppresses microglia-dependent phagocytosis and monocyte transition to macrophages, impairing recovery in EAE
por: Wang, Huan, et al.
Publicado: (2021)

Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS
por: Schrewe, L., et al.
Publicado: (2015)

Lipocalin 2 is present in the EAE brain and is modulated by natalizumab
por: Marques, Fernanda, et al.
Publicado: (2012)

Oleanolic acid ameliorates intestinal alterations associated with EAE
por: Gutierrez, Beatriz, et al.
Publicado: (2020)

Prevention of EAE by tolerogenic vaccination with PEGylated antigenic peptides
por: Pfeil, Jennifer, et al.
Publicado: (2021)

Hormones in experimental autoimmune encephalomyelitis (EAE) animal models
por: Ghareghani, Majid, et al.
Publicado: (2021)

Regulation of B cell functions by S-nitrosoglutathione in the EAE model
por: Kim, Judong, et al.
Publicado: (2021)

CNS Pericytes Modulate Local T Cell Infiltration in EAE
por: Koch, Kathrin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6u0cnh8mql2d65n5i4omjd5rae